ImmunityBio, Inc. IBRX

Set alert

8.93 USD +0.64 (+7.72%)

At closeNov 4, 2026, 5:05 PM EST

8.81 -0.12 -1.34%

After hours · Nov 4, 5:05 PM ET

8.21 Day range 8.95

1.95 52-week range 12.43

Held by insiders 62.15%

Held by institutions 19.94%

Float held by institutions 52.70%

Institutions 513

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	3.22%	34,083,262	304.36M	Jun 29, 2026
State Street Corporation	2.02%	21,398,438	191.09M	Jun 29, 2026
Vanguard Portfolio Management LLC	1.69%	17,863,911	159.52M	Jun 29, 2026
Vanguard Capital Management LLC	1.48%	15,691,579	140.13M	Jun 29, 2026
Shaw D.E. & Co., Inc.	1.09%	11,551,019	103.15M	Jun 29, 2026
Two Sigma Investments, LP	1.05%	11,097,106	99.10M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.10%	11,702,382	104.50M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.09%	11,597,491	103.57M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	0.94%	9,991,183	89.22M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	0.79%	8,399,273	75.01M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund	0.46%	4,852,894	43.34M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.40%	4,230,859	37.78M	Aug 30, 2026

IBRX insiders
Insider	Relation	Latest transaction	Date	Shares held
ADCOCK RICHARD	Chief Executive Officer	Conversion of Exercise of derivative security	Feb 19, 2026	560,344
COHEN CHERYL L	Director	Sale	Oct 1, 2026	100,309
REGAN LAUER	Officer	Conversion of Exercise of derivative security	Feb 19, 2026	115,875
SACHS DAVID C	Chief Financial Officer	Conversion of Exercise of derivative security	Feb 19, 2026	300,143
SELECKY CHRISTOBEL E.	Director	Sale	Jun 30, 2026	0
SIMON BARRY J. M.D.	Director	Sale	Oct 4, 2026	2,777,790

Held by funds